돌아가기
Huagongshe화공사 화학 정보 인쇄 보고서 · 연구 참고용
HRID 50116생성일: 2026년 10월 24일

Methane → Losartan potassium salt

https://huagongshe.com/ko/reaction/50116

반응식

참여 물질

역할이름HCID투입량
반응물MethaneHCID 297—
반응물Potassium HydroxideHCID 14797—
반응물2-n-butyl-4-chloro 1-[(2'-(2-triphenylmethyl-2H-tetrazol-5-yl)-1,1'biphenyl-4-yl)-me thyl]-1H-imidazol-5-methanol methyl-isobutyl ketoneHCID 69886909—
용매EthanolHCID 702—
생성물Losartan potassium saltHCID 1147671088.4%

반응 조건

온도0 °C

반응 단계

In a 500 ml flask a mixture of 200 ml of dry ethanol, 20 g (0.026 mol) of 2-n-butyl-4-chloro-1-[(2′-(2-triphenylmethyl -2H-tetrazol-5-yl)-1,1′-biphenyl-4-yl)-methyl]1H-imidazol-5-methanol methyl-isobutyl ketone solvate and 1.45 g (0.026 mol) of potassium hydroxide was refluxed for 9 h, treated with 0.5 g of charcoal and filtered. The filtrate was concentrated to a volume of 30 ml under diminished pressure, and after addition of 150 ml of acetonitrile again to a volume: of 60 ml. The suspension was stirred at 0° C. for 1 h, the precipitated crystals were filtered, washed twice with 25 ml of cold acetonitrile and dried at 70° C. to give 10.6 g (88%) of the title compound.

출처 및 근거

DOI10.6084/m9.figshare.5104873.v1
특허 번호US06710183B2
출처 데이터셋uspto-grants-2004_03
ORD IDord-99fa2889009c44f08cb79bded6f748b6
출처 메모uspto-grants-2004_03